RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
  Emergency Medicine
  Internal Medicine
  Respiratory Medicine
   Asthma
   COPD
   Cystic Fibrosis
  Sexual Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Respiratory Medicine Channel

subscribe to Respiratory Medicine newsletter
Latest Research : Medicine : Respiratory Medicine

   EMAIL   |   PRINT
Home-Away®Oxygen System Approved by FDA for Easy Oxygen at Home

Apr 25, 2005 - 8:15:00 AM
“The revolutionary Home-Away System will enable patients on LTOT to remain mobile and maintain their quality of life. Additionally, it is exciting news for home healthcare providers because it eliminates costly and time-consuming deliveries while offering patients full mobility with the preferred form of ambulatory oxygen."

 
[RxPG] In-X Corporation, of Denver, CO, developer and manufacturer of home oxygen liquefaction systems received FDA Clearance today for the Home-Away® System. The Home-Away System enables patients with Long Term Oxygen Therapy (LTOT) needs to produce liquid oxygen in their home, thus eliminating the need for expensive deliveries.

“The revolutionary Home-Away System will enable patients on LTOT to remain mobile and maintain their quality of life. Additionally, it is exciting news for home healthcare providers because it eliminates costly and time-consuming deliveries while offering patients full mobility with the preferred form of ambulatory oxygen”, said Doug Powell, president of In-X Corporation.

The Home-Away System works in conjunction with any In-X approved oxygen concentrator to create liquid oxygen within the patient’s home. The system directs a portion of the oxygen flow from the concentrator directing it to a cryogenic cooling device, where it is condensed into liquid and stored within the system until it is ready to be transfilled into a portable liquid unit. The remaining oxygen gas produced by the concentrator is available for patient use at a flow of up to 3 lpm. The portable liquid unit is worn around the patient’s waist (similar to a fanny pack); weighs just 4.2 lbs when full and provides a typical patient with 6-8 hours of mobility per fill. The Home-Away System produces enough liquid oxygen for a patient to fill the portable liquid unit 3 times per day.

In-X anticipates having the Home-Away System ready for sale to home healthcare providers in the last quarter of 2005 with product delivery the first quarter of 2006.



Publication: U.S. Food and Drug Administration (FDA)
On the web: FDA 

Advertise in this space for $10 per month. Contact us today.


Related Respiratory Medicine News
Surgically treating GERD helps preserve lung function before and after transplantation
Breast-feeding babies staves off asthma risk
Mannose receptor plays a key role in allergic responses to cat dander
New genetic variants for COPD discovered in a groundbreaking study by SpiroMeta Consortium
Horse barn workers at high risk of respiratory symptoms
Carbon nanotubes can affect lung lining
Pirfenidone could be new agent for treatment of Idiopathic pulmonary fibrosis.
MEMS sensor for remote monitoring of asthmatic patients
Obese children have respiratory problems during surgery
New York Methodist Hospital to study airway bypass treatment for emphysema

Subscribe to Respiratory Medicine Newsletter

Enter your email address:


 Additional information about the news article
For more information on the new Home-Away System, call Doug Powell, President, In-X Corporation at (303) 574-3115 ext. 103.

Company Background – In-X Corporation
In-X Corporation is a developer of advanced respiratory care products and is the exclusive source for the Home-Away System. Founded in 1997, In-X Corporation is a medical technology company based in Denver, CO.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)